Taxotere lawsuits witnessed a spike with almost 219 cases filed between July and August, bringing the total to almost 1,500 cases pending in the U.S. District Court, Eastern District of Louisiana against Sanofi-Aventis. The lawsuits are filed by individuals who allege experiencing permanent hair loss by Taxotere while on a cancer treatment.
In October 2016, Taxotere |LS|Docetaxel|RS| Products Liability Litigation, MDL Docket No. 2740, was established to coordinate discovery and other pretrial proceedings under US District Judge, Kurt Engelhardt. Since then, there is a steady rise in the number of Taxotere lawsuits filed. The first bellwether trial is expected to be heard by the jury in September 2018. A Taxotere settlement conference is scheduled on June 29, 2018, ordered by Judge Engelhardt to be attended by the parties involved in the litigation; a Joint Confidential Status Report is also to be submitted following settlement negotiations by July 6, 2018.
